FILE PHOTO: Sen. John Thune (R-SD) speaks to Capitol Hill reporters following the Republicans’ weekly policy luncheon in Washington, U.S., July 31, 2018. REUTERS/Allison Shelley
WASHINGTON (Reuters) – The second most powerful Republican in the U.S. Senate on Thursday said that a Democratic plan on drug pricing would not survive in the Republican-dominated chamber, calling it “heavy-handed.”
Senator John Thune, who guides votes as the Republican whip, said the plan would be “dead on arrival” if it passed the Democrat-led House of Representatives and went to the Senate.
“It sounds like it’s a very, very heavy-handed government intervention in the marketplace and essentially kind of killing the free market for drugs,” Thune told reporters about the proposal released by House Speaker Nancy Pelosi.
Reporting by Richard Cowan; Writing by Lisa Lambert
more recommended stories
Texas doctor delivers woman’s baby 25 years after delivering her
A Texas doctor who delivered a.
Coronavirus Task Force’s Dr. Birx tells 9 cities ‘get on top of it’ as positive cases rise
White House coronavirus task force coordinator.
Relocating during the coronavirus pandemic? Beware of mold, experts warn
In the midst of the coronavirus pandemic,.
Mother dies after her cancer is presumed to be coronavirus: report
The mother of a five-year-old is.
Hair loss may be a coronavirus symptom, study finds
A recent survey identified dozens of.
90-minute coronavirus tests expected to be available to millions in Britain
The National Health Service stated it.
Ohio woman who received first US face transplant dead at 57
Connie Culp, the Ohio woman who.
Amid coronavirus, Alaska sees surge in syphilis cases
What are the most common STDs?.
COVID-19 patient didn’t recognize body after double transplant
A Chicago woman who last month.
Hydroxychloroquine banned by Ohio pharmacy board for coronavirus treatment
Starting on Thursday, Ohio pharmacies, clinics.